Data & Analysis
Data & Analysis · page 12
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 1)
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement surrounding the young industry’s potential, 2022 saw this wave break sooner than many expected. 2023 is expected to bring yet more change.
- Adult-Use
Business<em>Cann</em>’s Top 10 Stories of 2022 – A Sticky Year For European Cannabis Ends On A High
TWELVE months ago we were recapping on what many were calling a break- through year for European cannabis following dramatic events in Germany with the new Government promising the continent’s first legalised adult-use market.
- Adult-Use
As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year
EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced his intention to submit draft legislation for an adult-use cannabis market by the end of the year, hoping a fully fledged market could be launched by 2024.
- Data & Analysis
Exploring daily retail cannabis sales in Canada
The CCSI was assessed at C$5.22 per gram this week, down 0.6% from last week’s C$5.25 per gram.
- Adult-Use
New report shows how Thailand is leading Asia in cannabis revolution
The report has been published by Prohibition Partners.
- Data & Analysis
A look at Statistic Canada’s household expenditure data
The CCSI was assessed at C$5.38 per gram this week, down 0.8% from last week’s C$5.42 per gram.
- Adult-Use
German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found
EARLIER this month news broke that recent analysis conducted by the Bundestag’s scientific service suggested the creation of a legal recreational cannabis market could contravene a number of European treaties which Germany had signed.
- Data & Analysis
Cellular Goods white paper explores cannabinoids for skincare
The paper explores what Cellular Goods refers to as the ‘5 A’s of cannabinoid skincare’.
- Data & Analysis
A look at unpackaged cannabis production in Canada
The CCSI was assessed at C$5.41 per gram this week, down 0.4% from last week’s C$5.43 per gram.
- Companies
Juicy Fields’ Collapse – What We Know So Far
JUICY Fields, a cannabis crowdfunding company offering investors outlandish returns, has collapsed in a characteristically complex and opaque fashion.
- Data & Analysis
A look at legal vs illegal recreational cannabis spending
The CCSI was assessed at C$5.14 per gram this week, up 0.7% from last week’s C$5.11 per gram.
- Data & Analysis
New Data Reveals England’s Private Medical Cannabis Prescriptions In 2021 Were More Than 9 Times That Of 2020
FOLLOWING last week’s dramatic political developments in the UK, which saw nearly 50 Members of Parliament quit in 48 hours, the prospect of making medical cannabis more affordable and accessible for the UK’s estimated 1.4m patients has inevitably fallen further down the list of political priorities.
